SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $178,869,000 | +4.3% | 914,044 | -9.4% | 2.41% | -3.9% |
Q2 2020 | $171,520,000 | +46.0% | 1,009,417 | -0.9% | 2.50% | +26.6% |
Q1 2020 | $117,506,000 | -7.6% | 1,018,426 | -8.5% | 1.98% | +20.0% |
Q4 2019 | $127,217,000 | +30.7% | 1,113,399 | -2.3% | 1.65% | +22.1% |
Q3 2019 | $97,331,000 | +18.8% | 1,139,709 | -3.9% | 1.35% | +33.8% |
Q2 2019 | $81,899,000 | -4.6% | 1,185,735 | +1.0% | 1.01% | -7.1% |
Q1 2019 | $85,871,000 | +35.5% | 1,174,026 | +5.0% | 1.09% | +17.7% |
Q4 2018 | $63,381,000 | -21.2% | 1,118,626 | +7.3% | 0.92% | -7.9% |
Q3 2018 | $80,436,000 | +13.7% | 1,042,995 | -2.1% | 1.00% | +8.4% |
Q2 2018 | $70,738,000 | +29.7% | 1,065,495 | +2.2% | 0.92% | +24.7% |
Q1 2018 | $54,557,000 | +28.4% | 1,042,352 | +31.2% | 0.74% | +27.5% |
Q4 2017 | $42,497,000 | -6.4% | 794,336 | -4.8% | 0.58% | +0.3% |
Q3 2017 | $45,406,000 | +51.1% | 834,519 | +43.7% | 0.58% | +47.0% |
Q2 2017 | $30,049,000 | – | 580,766 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |